Articles

AAKP Testifies Before MEDCAC Panel on ESA Use in Kidney Transplant

David Scott
Tampa, FL; Thursday, January 20, 2011 – On Wednesday, January 19, 2011, the American Association of Kidney Patients (AAKP) testified before the Center for Medicare and Medicaid Services’(CMS) Medicare Evidence Development & Coverage Advisory Committee (MEDCAC) on the impact of erythropoiesis stimulating agents (ESAs)
Read More

AAKP Applauds Latest GAO Report on Oral Drugs and ESRD Bundle

David Scott
Tampa, FL; March 28, 2011 – The American Association of Kidney Patients today congratulated the Government Accountability Office, the GAO, on the report issued this week entitled End Stage Renal Disease: CMS Should Assess Adequacy of Payment When Certain Oral Drugs Are Included and Ensure Availability of Quality Monitoring Data.
Read More

AAKP Urges Senator Kerry to Support Home Hemodialysis Pilot Program

David Scott
TAMPA, Fla., April 30, 2008 – The American Association of Kidney Patients (AAKP) sent a letter to Sen. John Kerry (D – Massachusetts) asking him to support a Medicare sponsored home hemodialysis program. AAKP is the largest kidney patient organization in the United States founded and directed by patients.
Read More

AAKP Seeks Senate Support of Drug Coverage for Transplant Recipients

David Scott
Tampa, Fla., May 1, 2008 – The American Association of Kidney Patients (AAKP) is seeking support from Congress members for S. 2320, the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007. The bill would extend Medicare coverage for immunosuppressive drugs for the life of the kidney.
Read More